613 results on '"Jackson, David C."'
Search Results
2. Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
3. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
4. Systems serology detects functionally distinct coronavirus antibody features in children and elderly
5. CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
6. The Toll-Like Receptor 2 agonist PEG-Pam2Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites
7. Human CD8+ T cell cross-reactivity across influenza A, B and C viruses
8. A Totally Synthetic Vaccine of Generic Structure That Targets Toll-Like Receptor 2 on Dendritic Cells and Promotes Antibody or Cytotoxic T Cell Responses
9. Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
10. PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8+ T cell responses
11. Development of Matrix-Embedded Bovine Tracheal Organoids to Study the Innate Immune Response against Bovine Respiratory Disease
12. Establishment of functional influenza virus-specific CD8+ T cell memory pools after intramuscular immunization
13. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate
14. Structure–function relationships of protein–lipopeptide complexes and influence on immunogenicity
15. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
16. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis
17. Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
18. Preemptive priming readily overcomes structure-based mechanisms of virus escape
19. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
20. Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions
21. Polyfunctional CD8+ T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope
22. Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides
23. Chitosan-based particles as biocompatible delivery vehicles for peptide and protein-based vaccines
24. Pulled from all angles … with strings attached
25. Promiscuous Peptide of 16 kDa Antigen Linked to Pam2Cys Protects Against Mycobacterium tuberculosis by Evoking Enduring Memory T-Cell Response
26. Protection against Heterologous Human Papillomavirus Challenge by a Synthetic Lipopeptide Vaccine Containing a Broadly Cross-Neutralizing Epitope of L2
27. Lipidation of intact proteins produces highly immunogenic vaccine candidates
28. Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection
29. Intranasal Vaccination with a Lipopeptide Containing a Conformationally Constrained Conserved Minimal Peptide, a Universal T Cell Epitope, and a Self-Adjuvanting Lipid Protects Mice from Group A Streptococcus Challenge and Reduces Throat Colonization
30. Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam2Cys
31. Reducing the impact of influenza-associated secondary pneumococcal infections
32. The endogenous inflammatory reflex inhibits the inflammatory response to different immune challenges in mice
33. Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2
34. Bovine and Mouse Serum β Inhibitors of Influenza A Viruses are Mannose-Binding Lectins
35. Valve Ultrastructure of Species of the Diatom Genera Gyrosigma and Pleurosigma from the Portage River Drainage System, Ohio
36. Individual Rights and National Security
37. The Transfer of Immovables
38. Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells
39. Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells
40. Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells
41. A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection
42. Branched and linear lipopeptide vaccines have different effects on primary CD4 + and CD8 + T-cell activation but induce similar tumor-protective memory CD8 + T-cell responses
43. Considerations for the rapid deployment of vaccines against H7N9 influenza
44. The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses
45. Selecting and Using the Appropriate Influenza Vaccine for Each Individual
46. TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs
47. Simple Branched Arginine-Based Structures can Enhance the Cellular Uptake of Peptide Cargos
48. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds
49. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups
50. The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.